Review



cxcl10  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems cxcl10
    Cxcl10, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 31 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl2/Recombinant+Mouse+CXCL2%2FMIP-2+Protein/pm41891183-606-80-81
    Average 94 stars, based on 31 article reviews
    cxcl10 - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Immunofluorescence:

    Article Title: Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance.
    Article Snippet: Fluorescence intensity was measured with ImageJ (version 1.54) after background subtraction. .. For immunofluorescence staining, cultured cells were fixed with 4% PFA, permeabilized with 0.1% Triton X-100 for 10 min and blocked with 5% horse serum before incubation with primary antibodies (XRCC4, 1:200 dilution, sc-271087, Santa Cruz; CXCL2, 1:50 dilution, AF-452-NA, R&D Systems; GROα/β/γ, 1:50 dilution, sc-365870, Santa Cruz; CXCL5, 1:50 dilution, AF254, R&D Systems; CCL20, 1:50 dilution, AF360, R&D Systems; MMP3, 1:50 dilution, 66338-1-lg, Proteintech) overnight at 4 °C. ..

    Article Title: Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance
    Article Snippet: Fluorescence intensity was measured with ImageJ (version 1.54) after background subtraction. .. For immunofluorescence staining, cultured cells were fixed with 4% PFA, permeabilized with 0.1% Triton X-100 for 10 min and blocked with 5% horse serum before incubation with primary antibodies (XRCC4, 1:200 dilution, sc-271087, Santa Cruz; CXCL2, 1:50 dilution, AF-452-NA, R&D Systems; GROα/β/γ, 1:50 dilution, sc-365870, Santa Cruz; CXCL5, 1:50 dilution, AF254, R&D Systems; CCL20, 1:50 dilution, AF360, R&D Systems; MMP3, 1:50 dilution, 66338-1-lg, Proteintech) overnight at 4 °C. ..

    Staining:

    Article Title: Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance.
    Article Snippet: Fluorescence intensity was measured with ImageJ (version 1.54) after background subtraction. .. For immunofluorescence staining, cultured cells were fixed with 4% PFA, permeabilized with 0.1% Triton X-100 for 10 min and blocked with 5% horse serum before incubation with primary antibodies (XRCC4, 1:200 dilution, sc-271087, Santa Cruz; CXCL2, 1:50 dilution, AF-452-NA, R&D Systems; GROα/β/γ, 1:50 dilution, sc-365870, Santa Cruz; CXCL5, 1:50 dilution, AF254, R&D Systems; CCL20, 1:50 dilution, AF360, R&D Systems; MMP3, 1:50 dilution, 66338-1-lg, Proteintech) overnight at 4 °C. ..

    Article Title: Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance
    Article Snippet: Fluorescence intensity was measured with ImageJ (version 1.54) after background subtraction. .. For immunofluorescence staining, cultured cells were fixed with 4% PFA, permeabilized with 0.1% Triton X-100 for 10 min and blocked with 5% horse serum before incubation with primary antibodies (XRCC4, 1:200 dilution, sc-271087, Santa Cruz; CXCL2, 1:50 dilution, AF-452-NA, R&D Systems; GROα/β/γ, 1:50 dilution, sc-365870, Santa Cruz; CXCL5, 1:50 dilution, AF254, R&D Systems; CCL20, 1:50 dilution, AF360, R&D Systems; MMP3, 1:50 dilution, 66338-1-lg, Proteintech) overnight at 4 °C. ..

    Article Title: Spatially separated epithelium-associated and lamina propria neutrophils present distinct functional identities in the inflamed colon mucosa
    Article Snippet: Following cell surface staining, cells were washed and fixed/permeabilized with BD Cytofix/Cytoperm solution (554722, BD Biosciences, San Jose, CA) for 20 min at 4 °C. .. Following serial washes with 1x BD Perm/Wash buffer (554723), cells were stained for intracellular markers such as TNFα (MP6-XT22), pro-IL1β (NJTEN3), CXCL2 (AF452-NA, R&D Systems, Minneapolis, MN) overnight at 4 °C (1:100 each). ..

    Cell Culture:

    Article Title: Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance.
    Article Snippet: Fluorescence intensity was measured with ImageJ (version 1.54) after background subtraction. .. For immunofluorescence staining, cultured cells were fixed with 4% PFA, permeabilized with 0.1% Triton X-100 for 10 min and blocked with 5% horse serum before incubation with primary antibodies (XRCC4, 1:200 dilution, sc-271087, Santa Cruz; CXCL2, 1:50 dilution, AF-452-NA, R&D Systems; GROα/β/γ, 1:50 dilution, sc-365870, Santa Cruz; CXCL5, 1:50 dilution, AF254, R&D Systems; CCL20, 1:50 dilution, AF360, R&D Systems; MMP3, 1:50 dilution, 66338-1-lg, Proteintech) overnight at 4 °C. ..

    Article Title: Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance
    Article Snippet: Fluorescence intensity was measured with ImageJ (version 1.54) after background subtraction. .. For immunofluorescence staining, cultured cells were fixed with 4% PFA, permeabilized with 0.1% Triton X-100 for 10 min and blocked with 5% horse serum before incubation with primary antibodies (XRCC4, 1:200 dilution, sc-271087, Santa Cruz; CXCL2, 1:50 dilution, AF-452-NA, R&D Systems; GROα/β/γ, 1:50 dilution, sc-365870, Santa Cruz; CXCL5, 1:50 dilution, AF254, R&D Systems; CCL20, 1:50 dilution, AF360, R&D Systems; MMP3, 1:50 dilution, 66338-1-lg, Proteintech) overnight at 4 °C. ..

    Incubation:

    Article Title: Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance.
    Article Snippet: Fluorescence intensity was measured with ImageJ (version 1.54) after background subtraction. .. For immunofluorescence staining, cultured cells were fixed with 4% PFA, permeabilized with 0.1% Triton X-100 for 10 min and blocked with 5% horse serum before incubation with primary antibodies (XRCC4, 1:200 dilution, sc-271087, Santa Cruz; CXCL2, 1:50 dilution, AF-452-NA, R&D Systems; GROα/β/γ, 1:50 dilution, sc-365870, Santa Cruz; CXCL5, 1:50 dilution, AF254, R&D Systems; CCL20, 1:50 dilution, AF360, R&D Systems; MMP3, 1:50 dilution, 66338-1-lg, Proteintech) overnight at 4 °C. ..

    Article Title: Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance
    Article Snippet: Fluorescence intensity was measured with ImageJ (version 1.54) after background subtraction. .. For immunofluorescence staining, cultured cells were fixed with 4% PFA, permeabilized with 0.1% Triton X-100 for 10 min and blocked with 5% horse serum before incubation with primary antibodies (XRCC4, 1:200 dilution, sc-271087, Santa Cruz; CXCL2, 1:50 dilution, AF-452-NA, R&D Systems; GROα/β/γ, 1:50 dilution, sc-365870, Santa Cruz; CXCL5, 1:50 dilution, AF254, R&D Systems; CCL20, 1:50 dilution, AF360, R&D Systems; MMP3, 1:50 dilution, 66338-1-lg, Proteintech) overnight at 4 °C. ..

    Enzyme-linked Immunosorbent Assay:

    Article Title: Type I interferon protects against bone loss in periodontitis by mitigating an interleukin (IL)-17-neutrophil axis.
    Article Snippet: .. The level of CXCL1 (catalog # DY-453-5), CXCL2 (catalog # DY452-05), IL-6 (catalog # DY406-05), IL-1β (catalog # DY401-05), and IL-10 (catalog # DY417-05) was measured by a DuoSet ELISA kit (R&D systems, USA) following the manufacturer’s instructions. ..

    Article Title: Hydrogen Peroxide and Neutrophil Chemotaxis in a Mouse Model of Bacterial Infection
    Article Snippet: Artesunate (A3731), Dulbecco’s Modified Eagle’s Medium (DMEM, D0822), Foetal Bovine Serum (FBS, F7524), Phosphate-Buffered Saline (PBS, P4474) and Liberase Thermolysin Low (TL) (05401020001) were purchased from Merck Life Sciences (Feltham, UK). .. DuoSet Enzyme-Linked Immunosorbent Assay (ELISA) kits for CXCL1 (DY453), CXCL2 (DY452), IL-6 (DY406) and IL-1β (DY401) were purchased from R&D Systems (Bio-Techne, Oxford, UK). .. Cell-free (Cf) Deoxyribonucleic acid (DNA) kit (Quant-ITTM PicoGreen®, P7589) was purchased from Thermo Fisher Scientific (Waltham, MA, USA).

    Purification:

    Article Title: Substance P Augments Chemokine Production by Staphylococcus aureus Infected Murine Osteoclasts.
    Article Snippet: Enzyme‐Linked Immunosorbent Assays (ELISAs) ELISAs were conducted on T-PER bone tissue protein isolates, cell culture supernatants, or cell protein isolates processed using mammalian protein extraction reagent (M-PER, Thermo Fisher) to quantify inflammatory mediator production in response to S. aureus infection at the indicated time points. .. The inflammatory immune mediators analyzed were TNF, IL-1β, CXCL1, CXCL2, CXCL5, CCL2, CCL4, CCL7, MMP-9, myeloperoxidase (MPO) and cathepsin K. A purified goat or rat anti-mouse capture antibody for TNF (Cat# DY410-05, 0.8 μg/mL), IL-1β (Cat# DY401-05, 4 μg/ mL), CXCL1 (Cat# DY453-05, 2 μg/mL), CXCL2 (Cat# DY452-05, 2 μg/mL), CXCL5 (Cat# DY443, 4 μg/mL), MMP-9 (Cat#DY6718, 2 μg/mL), and MPO (Cat# DY3667, 0.8 μg/mL) and a biotinylated goat or rat anti-mouse detection antibody for TNF (Cat# 410–05, 0.0375 μg/mL), IL-1β (Cat# DY401-05, 0.5 μg/mL), CXCL1 (Cat# DY453-05, 0.05 μg/mL), CXCL2 (Cat# DY452-05, 0.075 μg/mL), CXCL5 (Cat# DY443, 0.05 μg/mL), MMP-9 (Cat#DY6718, 100 ng/mL), and MPO (Cat# DY3667, 0.05 μg/mL) were used to quantify the respective mouse protein concentrations according the manufacturer’s guidelines (R&D Systems). .. A purified rat anti-mouse CCL7 capture antibody (Abcam, Cat# 210,889–5, 2 μg/mL) and a biotinylated rat anti-mouse CCL7 detection antibody (Abcam, Cat# 210,889–5, 0.05 μg/ mL) were utilized to quantify mouse CCL7 concentrations.

    Article Title: Substance P Augments Chemokine Production by Staphylococcus aureus Infected Murine Osteoclasts
    Article Snippet: ELISAs were conducted on T-PER bone tissue protein isolates, cell culture supernatants, or cell protein isolates processed using mammalian protein extraction reagent (M-PER, Thermo Fisher) to quantify inflammatory mediator production in response to S. aureus infection at the indicated time points. .. The inflammatory immune mediators analyzed were TNF, IL-1β, CXCL1, CXCL2, CXCL5, CCL2, CCL4, CCL7, MMP-9, myeloperoxidase (MPO) and cathepsin K. A purified goat or rat anti-mouse capture antibody for TNF (Cat# DY410–05, 0.8 μg/mL), IL-1β (Cat# DY401–05, 4 μg/mL), CXCL1 (Cat# DY453–05, 2 μg/mL), CXCL2 (Cat# DY452–05, 2 μg/mL), CXCL5 (Cat# DY443, 4 μg/mL), MMP-9 (Cat#DY6718, 2 μg/mL), and MPO (Cat# DY3667, 0.8 μg/mL) and a biotinylated goat or rat anti-mouse detection antibody for TNF (Cat# 410–05, 0.0375 μg/mL), IL-1β (Cat# DY401–05, 0.5 μg/mL), CXCL1 (Cat# DY453–05, 0.05 μg/mL), CXCL2 (Cat# DY452–05, 0.075 μg/mL), CXCL5 (Cat# DY443, 0.05 μg/mL), MMP-9 (Cat#DY6718, 100 ng/mL), and MPO (Cat# DY3667, 0.05 μg/mL) were used to quantify the respective mouse protein concentrations according the manufacturer’s guidelines (R&D Systems). .. A purified rat anti-mouse CCL7 capture antibody (Abcam, Cat# 210,889–5, 2 μg/mL) and a biotinylated rat anti-mouse CCL7 detection antibody (Abcam, Cat# 210,889–5, 0.05 μg/mL) were utilized to quantify mouse CCL7 concentrations.



    Similar Products

    gene exp cxcl2 mm00436450 m1  (Thermo Fisher)
    99
    Thermo Fisher gene exp cxcl2 mm00436450 m1
    Gene Exp Cxcl2 Mm00436450 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl2/Gene+Exp%2E+Cxcl2%2C+Mm00436450_m1/pm41999653-94-30-17
    Average 99 stars, based on 1 article reviews
    gene exp cxcl2 mm00436450 m1 - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    cxcl2 recombinant protein  (MedChemExpress)
    94
    MedChemExpress cxcl2 recombinant protein
    ScRNA-seq analysis identified macrophage-specific genes associated with immunotherapy response in ESCC. (A) UMAP plot of single cells from patients with ESCC in GSE203115 cohort. (B) Heatmap of marker genes in each single cell subcluster based on the clustering analysis. (C, D) GO and KEGG analyses of differentially expressed genes in macrophages between the responsive and non-responsive groups. (E) Venn diagram of intersected gene in the indicated three signaling pathways. (F) <t>CXCL2</t> expression levels on macrophages in the responding and non-responding groups. ESCC, esophageal squamous cell carcinoma; CXCL2, CXC chemokine ligand 2; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; UMAP, Uniform Manifold Approximation and Projection; scRNA-seq, single-cell RNA sequencing.
    Cxcl2 Recombinant Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl2/MIP-2%2FCXCL2%2C+Mouse/pmc13111272-74-28-33
    Average 94 stars, based on 1 article reviews
    cxcl2 recombinant protein - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    cxcl2  (Elabscience Biotechnology)
    93
    Elabscience Biotechnology cxcl2
    ScRNA-seq analysis identified macrophage-specific genes associated with immunotherapy response in ESCC. (A) UMAP plot of single cells from patients with ESCC in GSE203115 cohort. (B) Heatmap of marker genes in each single cell subcluster based on the clustering analysis. (C, D) GO and KEGG analyses of differentially expressed genes in macrophages between the responsive and non-responsive groups. (E) Venn diagram of intersected gene in the indicated three signaling pathways. (F) <t>CXCL2</t> expression levels on macrophages in the responding and non-responding groups. ESCC, esophageal squamous cell carcinoma; CXCL2, CXC chemokine ligand 2; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; UMAP, Uniform Manifold Approximation and Projection; scRNA-seq, single-cell RNA sequencing.
    Cxcl2, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl2/Human+GRO%CE%B2%2FCXCL2+(Growth+Regulated+Oncogene+Beta)+ELISA+Kit/10__1186_slash_s43162___026___00624___z-69-20-37
    Average 93 stars, based on 1 article reviews
    cxcl2 - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    cxcl10  (R&D Systems)
    94
    R&D Systems cxcl10
    ScRNA-seq analysis identified macrophage-specific genes associated with immunotherapy response in ESCC. (A) UMAP plot of single cells from patients with ESCC in GSE203115 cohort. (B) Heatmap of marker genes in each single cell subcluster based on the clustering analysis. (C, D) GO and KEGG analyses of differentially expressed genes in macrophages between the responsive and non-responsive groups. (E) Venn diagram of intersected gene in the indicated three signaling pathways. (F) <t>CXCL2</t> expression levels on macrophages in the responding and non-responding groups. ESCC, esophageal squamous cell carcinoma; CXCL2, CXC chemokine ligand 2; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; UMAP, Uniform Manifold Approximation and Projection; scRNA-seq, single-cell RNA sequencing.
    Cxcl10, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl2/Recombinant+Mouse+CXCL2%2FMIP-2+Protein/pm41891183-606-80-81
    Average 94 stars, based on 1 article reviews
    cxcl10 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    cxcl2  (R&D Systems)
    94
    R&D Systems cxcl2
    ScRNA-seq analysis identified macrophage-specific genes associated with immunotherapy response in ESCC. (A) UMAP plot of single cells from patients with ESCC in GSE203115 cohort. (B) Heatmap of marker genes in each single cell subcluster based on the clustering analysis. (C, D) GO and KEGG analyses of differentially expressed genes in macrophages between the responsive and non-responsive groups. (E) Venn diagram of intersected gene in the indicated three signaling pathways. (F) <t>CXCL2</t> expression levels on macrophages in the responding and non-responding groups. ESCC, esophageal squamous cell carcinoma; CXCL2, CXC chemokine ligand 2; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; UMAP, Uniform Manifold Approximation and Projection; scRNA-seq, single-cell RNA sequencing.
    Cxcl2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl2/Recombinant+Mouse+CCL12%2FMCP-5+Protein/pm41891183-606-74-75
    Average 94 stars, based on 1 article reviews
    cxcl2 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    cxcl2  (Jiancheng Inc)
    86
    Jiancheng Inc cxcl2
    ScRNA-seq analysis identified macrophage-specific genes associated with immunotherapy response in ESCC. (A) UMAP plot of single cells from patients with ESCC in GSE203115 cohort. (B) Heatmap of marker genes in each single cell subcluster based on the clustering analysis. (C, D) GO and KEGG analyses of differentially expressed genes in macrophages between the responsive and non-responsive groups. (E) Venn diagram of intersected gene in the indicated three signaling pathways. (F) <t>CXCL2</t> expression levels on macrophages in the responding and non-responding groups. ESCC, esophageal squamous cell carcinoma; CXCL2, CXC chemokine ligand 2; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; UMAP, Uniform Manifold Approximation and Projection; scRNA-seq, single-cell RNA sequencing.
    Cxcl2, supplied by Jiancheng Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl2/cxcl1/pm41861962-110-36-43
    Average 86 stars, based on 1 article reviews
    cxcl2 - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    gene exp cxcl2 hs00236966 m1  (Thermo Fisher)
    85
    Thermo Fisher gene exp cxcl2 hs00236966 m1
    ScRNA-seq analysis identified macrophage-specific genes associated with immunotherapy response in ESCC. (A) UMAP plot of single cells from patients with ESCC in GSE203115 cohort. (B) Heatmap of marker genes in each single cell subcluster based on the clustering analysis. (C, D) GO and KEGG analyses of differentially expressed genes in macrophages between the responsive and non-responsive groups. (E) Venn diagram of intersected gene in the indicated three signaling pathways. (F) <t>CXCL2</t> expression levels on macrophages in the responding and non-responding groups. ESCC, esophageal squamous cell carcinoma; CXCL2, CXC chemokine ligand 2; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; UMAP, Uniform Manifold Approximation and Projection; scRNA-seq, single-cell RNA sequencing.
    Gene Exp Cxcl2 Hs00236966 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl2/Gene+Exp%2E+CXCL2%2C+Hs00236966_m1/pm41819084-757-50-51
    Average 85 stars, based on 1 article reviews
    gene exp cxcl2 hs00236966 m1 - by Bioz Stars, 2026-09
    85/100 stars
    		  Buy from Supplier
    gene exp cxcl2 rn00586403 m1  (Thermo Fisher)
    89
    Thermo Fisher gene exp cxcl2 rn00586403 m1
    ScRNA-seq analysis identified macrophage-specific genes associated with immunotherapy response in ESCC. (A) UMAP plot of single cells from patients with ESCC in GSE203115 cohort. (B) Heatmap of marker genes in each single cell subcluster based on the clustering analysis. (C, D) GO and KEGG analyses of differentially expressed genes in macrophages between the responsive and non-responsive groups. (E) Venn diagram of intersected gene in the indicated three signaling pathways. (F) <t>CXCL2</t> expression levels on macrophages in the responding and non-responding groups. ESCC, esophageal squamous cell carcinoma; CXCL2, CXC chemokine ligand 2; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; UMAP, Uniform Manifold Approximation and Projection; scRNA-seq, single-cell RNA sequencing.
    Gene Exp Cxcl2 Rn00586403 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 89/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl2/Gene+Exp%2E+Cxcl2%2C+Rn00586403_m1/pm41814667-109-29--1
    Average 89 stars, based on 1 article reviews
    gene exp cxcl2 rn00586403 m1 - by Bioz Stars, 2026-09
    89/100 stars
    		  Buy from Supplier
    mip 2  (R&D Systems)
    95
    R&D Systems mip 2
    ScRNA-seq analysis identified macrophage-specific genes associated with immunotherapy response in ESCC. (A) UMAP plot of single cells from patients with ESCC in GSE203115 cohort. (B) Heatmap of marker genes in each single cell subcluster based on the clustering analysis. (C, D) GO and KEGG analyses of differentially expressed genes in macrophages between the responsive and non-responsive groups. (E) Venn diagram of intersected gene in the indicated three signaling pathways. (F) <t>CXCL2</t> expression levels on macrophages in the responding and non-responding groups. ESCC, esophageal squamous cell carcinoma; CXCL2, CXC chemokine ligand 2; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; UMAP, Uniform Manifold Approximation and Projection; scRNA-seq, single-cell RNA sequencing.
    Mip 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl2/Mouse+CXCL2%2FMIP-2+Quantikine+ELISA+Kit/pm41812248-49-21-65
    Average 95 stars, based on 1 article reviews
    mip 2 - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    ScRNA-seq analysis identified macrophage-specific genes associated with immunotherapy response in ESCC. (A) UMAP plot of single cells from patients with ESCC in GSE203115 cohort. (B) Heatmap of marker genes in each single cell subcluster based on the clustering analysis. (C, D) GO and KEGG analyses of differentially expressed genes in macrophages between the responsive and non-responsive groups. (E) Venn diagram of intersected gene in the indicated three signaling pathways. (F) CXCL2 expression levels on macrophages in the responding and non-responding groups. ESCC, esophageal squamous cell carcinoma; CXCL2, CXC chemokine ligand 2; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; UMAP, Uniform Manifold Approximation and Projection; scRNA-seq, single-cell RNA sequencing.

    Journal: Frontiers in Immunology

    Article Title: CXCL2 affects macrophage antitumor function and immunotherapy efficacy in esophageal squamous cell carcinoma through calcium signaling

    doi: 10.3389/fimmu.2026.1695387

    Figure Lengend Snippet: ScRNA-seq analysis identified macrophage-specific genes associated with immunotherapy response in ESCC. (A) UMAP plot of single cells from patients with ESCC in GSE203115 cohort. (B) Heatmap of marker genes in each single cell subcluster based on the clustering analysis. (C, D) GO and KEGG analyses of differentially expressed genes in macrophages between the responsive and non-responsive groups. (E) Venn diagram of intersected gene in the indicated three signaling pathways. (F) CXCL2 expression levels on macrophages in the responding and non-responding groups. ESCC, esophageal squamous cell carcinoma; CXCL2, CXC chemokine ligand 2; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; UMAP, Uniform Manifold Approximation and Projection; scRNA-seq, single-cell RNA sequencing.

    Article Snippet: Once tumors became palpable (approximately 5–7 days post-injection), the mice were randomly divided into groups (5 mice per group) and treated as follows: intraperitoneal injection of 100 μg CXCL2 recombinant protein (Cat. HY-P7258; MCE) once every two days, 150 μg anti-PD-1 antibody (Cat. BP0273; BioX Cell) once every three days , or the combination of both.

    Techniques: Marker, Single Cell, Protein-Protein interactions, Expressing, RNA Sequencing

    High infiltration of CXCL2 + macrophages is positively associated with favorable prognosis in ESCC patients. (A) Representative images of immunofluorescence co-staining of CD68 (red) and CXCL2 (green) in ESCC tissues. Scale bar, 20µm (left) and 5µm (right). (B) Pearson correlation analysis of CXCL2 expression level with the infiltration proportion of M1 or M2 macrophage in ESCC. (C) Kaplan-Meier curve for PFS of patients with low or high CXCL2 expression in TCGA cohort. Log-rank test. (D) Kaplan-Meier curve for OS of patients with low or high CXCL2 + macrophage population in our ESCC patient cohort. Log-rank test. (E) Forest plot illustrating the univariate and multivariate Cox proportional hazards regression models for OS in ESCC patients from our own cohort. ESCC, esophageal squamous cell carcinoma; CXCL2, CXC chemokine ligand 2; OS, overall survival; PFS, Progression-free survival; TNM, tumor-node-metastasis; HR, hazard ratio; CI, confidence interval.

    Journal: Frontiers in Immunology

    Article Title: CXCL2 affects macrophage antitumor function and immunotherapy efficacy in esophageal squamous cell carcinoma through calcium signaling

    doi: 10.3389/fimmu.2026.1695387

    Figure Lengend Snippet: High infiltration of CXCL2 + macrophages is positively associated with favorable prognosis in ESCC patients. (A) Representative images of immunofluorescence co-staining of CD68 (red) and CXCL2 (green) in ESCC tissues. Scale bar, 20µm (left) and 5µm (right). (B) Pearson correlation analysis of CXCL2 expression level with the infiltration proportion of M1 or M2 macrophage in ESCC. (C) Kaplan-Meier curve for PFS of patients with low or high CXCL2 expression in TCGA cohort. Log-rank test. (D) Kaplan-Meier curve for OS of patients with low or high CXCL2 + macrophage population in our ESCC patient cohort. Log-rank test. (E) Forest plot illustrating the univariate and multivariate Cox proportional hazards regression models for OS in ESCC patients from our own cohort. ESCC, esophageal squamous cell carcinoma; CXCL2, CXC chemokine ligand 2; OS, overall survival; PFS, Progression-free survival; TNM, tumor-node-metastasis; HR, hazard ratio; CI, confidence interval.

    Article Snippet: Once tumors became palpable (approximately 5–7 days post-injection), the mice were randomly divided into groups (5 mice per group) and treated as follows: intraperitoneal injection of 100 μg CXCL2 recombinant protein (Cat. HY-P7258; MCE) once every two days, 150 μg anti-PD-1 antibody (Cat. BP0273; BioX Cell) once every three days , or the combination of both.

    Techniques: Immunofluorescence, Staining, Expressing

    CXCL2 regulated the transition of macrophages to an immune-activated state by mediating cytoplasmic calcium influx. (A) Volcano plot of DEGs between DMSO and CXCL2 treatment groups. (B, C) GO and KEGG analysis of DEGs between DMSO and CXCL2 treatment groups. (D) Flow cytometric analysis of fluo‐3AM positive BMDMs following DMSO and CXCL2 treatment groups. (E) qPCR detecting the indicated genes expression levels on BMDMs in DMSO and CXCL2 treatment groups. (F) Flow cytometry analysis of MHC-II expression on BMDMs in DMSO and CXCL2 treatment groups. (G) qPCR detecting the indicated genes expression levels on BMDMs in the indicated groups. (H) Flow cytometry analysis of MHC-II expression on BMDMs in the indicated groups. * P < 0.05, ** P < 0.01, *** P < 0.001, and NS, not significant; Student’s t-test or one-way ANOVA test. CXCL2, CXC chemokine ligand 2; DMSO, dimethyl sulfoxide; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; MFI, median fluorescence intensity; ANOVA, analysis of variance; BMDMs, bone marrow-derived macrophages; DEG, differentially expressed gene; MHC, major histocompatibility complex; mRNA, messenger RNA; qPCR, quantitative PCR.

    Journal: Frontiers in Immunology

    Article Title: CXCL2 affects macrophage antitumor function and immunotherapy efficacy in esophageal squamous cell carcinoma through calcium signaling

    doi: 10.3389/fimmu.2026.1695387

    Figure Lengend Snippet: CXCL2 regulated the transition of macrophages to an immune-activated state by mediating cytoplasmic calcium influx. (A) Volcano plot of DEGs between DMSO and CXCL2 treatment groups. (B, C) GO and KEGG analysis of DEGs between DMSO and CXCL2 treatment groups. (D) Flow cytometric analysis of fluo‐3AM positive BMDMs following DMSO and CXCL2 treatment groups. (E) qPCR detecting the indicated genes expression levels on BMDMs in DMSO and CXCL2 treatment groups. (F) Flow cytometry analysis of MHC-II expression on BMDMs in DMSO and CXCL2 treatment groups. (G) qPCR detecting the indicated genes expression levels on BMDMs in the indicated groups. (H) Flow cytometry analysis of MHC-II expression on BMDMs in the indicated groups. * P < 0.05, ** P < 0.01, *** P < 0.001, and NS, not significant; Student’s t-test or one-way ANOVA test. CXCL2, CXC chemokine ligand 2; DMSO, dimethyl sulfoxide; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; MFI, median fluorescence intensity; ANOVA, analysis of variance; BMDMs, bone marrow-derived macrophages; DEG, differentially expressed gene; MHC, major histocompatibility complex; mRNA, messenger RNA; qPCR, quantitative PCR.

    Article Snippet: Once tumors became palpable (approximately 5–7 days post-injection), the mice were randomly divided into groups (5 mice per group) and treated as follows: intraperitoneal injection of 100 μg CXCL2 recombinant protein (Cat. HY-P7258; MCE) once every two days, 150 μg anti-PD-1 antibody (Cat. BP0273; BioX Cell) once every three days , or the combination of both.

    Techniques: Expressing, Flow Cytometry, Fluorescence, Derivative Assay, Immunopeptidomics, Real-time Polymerase Chain Reaction

    CXCL2 inhibits tumor growth in the mouse ESCC subcutaneous tumor model. (A) Gross appearance of subcutaneous ESCC tumors in each treatment group. (B) Changes in subcutaneous tumor volumes in each group during the experiment. (C, D) Tumor volumes and weights in each group at the end of the experiment. (E, F) Flow cytometry analysis depicting the proportion of CD11b + F4/80 + MHCII + macrophages and CD3 + CD8 + T cells in each group. * P < 0.05, ** P < 0.01, *** P < 0.001, and NS, not significant; one-way ANOVA test. CXC chemokine ligand 2; ANOVA, analysis of variance; ESCC, esophageal squamous cell carcinoma; MHC, major histocompatibility complex.

    Journal: Frontiers in Immunology

    Article Title: CXCL2 affects macrophage antitumor function and immunotherapy efficacy in esophageal squamous cell carcinoma through calcium signaling

    doi: 10.3389/fimmu.2026.1695387

    Figure Lengend Snippet: CXCL2 inhibits tumor growth in the mouse ESCC subcutaneous tumor model. (A) Gross appearance of subcutaneous ESCC tumors in each treatment group. (B) Changes in subcutaneous tumor volumes in each group during the experiment. (C, D) Tumor volumes and weights in each group at the end of the experiment. (E, F) Flow cytometry analysis depicting the proportion of CD11b + F4/80 + MHCII + macrophages and CD3 + CD8 + T cells in each group. * P < 0.05, ** P < 0.01, *** P < 0.001, and NS, not significant; one-way ANOVA test. CXC chemokine ligand 2; ANOVA, analysis of variance; ESCC, esophageal squamous cell carcinoma; MHC, major histocompatibility complex.

    Article Snippet: Once tumors became palpable (approximately 5–7 days post-injection), the mice were randomly divided into groups (5 mice per group) and treated as follows: intraperitoneal injection of 100 μg CXCL2 recombinant protein (Cat. HY-P7258; MCE) once every two days, 150 μg anti-PD-1 antibody (Cat. BP0273; BioX Cell) once every three days , or the combination of both.

    Techniques: Flow Cytometry, Immunopeptidomics

    CXCL2 enhances the efficacy of anti-PD-1 antibody in ESCC in vivo . (A) Schematic of the schedule of anti-PD-1 antibody and CXCL2 treatment in AKR cell-derived subcutaneous ESCC mouse models. (B) Changes in subcutaneous tumor volumes in each group during the experiment. (C, D) Tumor volumes and weights in each group at the end of the experiment. (E, F) Flow cytometry analysis depicting the proportion of CD11b + F4/80 + MHCII + macrophages and CD3 + CD8 + T cells in each group. (G) Schematic diagram illustrating the role of CXCL2 in macrophage and the microenvironment immune landscapes of ESCC. Patients with ESCC with immunotherapy responsive typically exhibit a significant infiltration of CXCL2 + macrophages, which facilitate the polarization of macrophages to an immune-activated state through calcium influx, thereby enhancing the cytotoxic function of CD8 + T cells. * P < 0.05, ** P < 0.01, *** P < 0.001, and NS, not significant; one-way ANOVA test. ANOVA, analysis of variance; ESCC, esophageal squamous cell carcinoma; CXC chemokine ligand 2; MHC, major histocompatibility complex; IgG, immunoglobulin G; PD-1, programmed cell death protein-1.

    Journal: Frontiers in Immunology

    Article Title: CXCL2 affects macrophage antitumor function and immunotherapy efficacy in esophageal squamous cell carcinoma through calcium signaling

    doi: 10.3389/fimmu.2026.1695387

    Figure Lengend Snippet: CXCL2 enhances the efficacy of anti-PD-1 antibody in ESCC in vivo . (A) Schematic of the schedule of anti-PD-1 antibody and CXCL2 treatment in AKR cell-derived subcutaneous ESCC mouse models. (B) Changes in subcutaneous tumor volumes in each group during the experiment. (C, D) Tumor volumes and weights in each group at the end of the experiment. (E, F) Flow cytometry analysis depicting the proportion of CD11b + F4/80 + MHCII + macrophages and CD3 + CD8 + T cells in each group. (G) Schematic diagram illustrating the role of CXCL2 in macrophage and the microenvironment immune landscapes of ESCC. Patients with ESCC with immunotherapy responsive typically exhibit a significant infiltration of CXCL2 + macrophages, which facilitate the polarization of macrophages to an immune-activated state through calcium influx, thereby enhancing the cytotoxic function of CD8 + T cells. * P < 0.05, ** P < 0.01, *** P < 0.001, and NS, not significant; one-way ANOVA test. ANOVA, analysis of variance; ESCC, esophageal squamous cell carcinoma; CXC chemokine ligand 2; MHC, major histocompatibility complex; IgG, immunoglobulin G; PD-1, programmed cell death protein-1.

    Article Snippet: Once tumors became palpable (approximately 5–7 days post-injection), the mice were randomly divided into groups (5 mice per group) and treated as follows: intraperitoneal injection of 100 μg CXCL2 recombinant protein (Cat. HY-P7258; MCE) once every two days, 150 μg anti-PD-1 antibody (Cat. BP0273; BioX Cell) once every three days , or the combination of both.

    Techniques: In Vivo, Derivative Assay, Flow Cytometry, Immunopeptidomics